Quantcast
Last updated on April 20, 2014 at 5:20 EDT

Latest insulin pump Stories

2011-12-01 17:05:00

FARMINGTON, Conn., Dec. 1, 2011 /PRNewswire-iReach/ -- Global Information, Inc. (GII) presents Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 by GlobalData. (Photo: http://photos.prnewswire.com/prnh/20111201/CG15956) Insulin pump are small computer-driven mechanical devices that deliver insulin in a precisely controlled manner at pre-programmed intervals, and are extremely helpful to diabetic patients who need several daily injections of...

2011-11-16 06:30:00

SAN DIEGO, Nov. 16, 2011 /PRNewswire/ -- Tandem Diabetes Care, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted the Company clearance to market the t:slim(TM) Insulin Delivery System (t:slim). This new full-featured pump is the first-ever with a color touch screen, and is the smallest insulin pump system currently available. The t:slim is one of the first insulin pumps to be cleared under the FDA's new Infusion Pump Improvement Initiative. "With the...

2011-11-14 11:21:50

NIH-funded study shows long-term benefits Controlling blood glucose early in the course of type 1 diabetes yields huge dividends, preserving kidney function for decades. The new finding from a study funded by the National Institutes of Health was published online in the New England Journal of Medicine Nov. 12 to coincide with presentation at a scientific meeting. Compared to conventional therapy, near-normal control of blood glucose beginning soon after diagnosis of type 1 diabetes and...

2011-11-14 11:20:34

Years later participants see benefits of good blood sugar control in reducing slow-progressing complications Maintaining good glucose control early in the course of type 1 diabetes could lessen the long-term risk of kidney disease, as measured by a common test of kidney function. This finding comes from more than two decades of research on preventing life-shortening complications of type 1 diabetes. The National Institutes of Health (NIH) funded the longitudinal study. Results will be...

2011-10-27 18:05:00

SAN DIEGO, Oct. 27, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced positive results from a study in patients with type 1 diabetes that receive their insulin therapy via pumps. The Phase 1b study was conducted as a randomized, double-blind, crossover design, to determine insulin...

2011-10-07 07:00:00

A team of researchers at the University of Sydney in Australia has discovered a new food insulin index (FII) algorithm for use in estimating the amount of insulin that Type 1 diabetics should receive when eating meals as reported by DiabeticLive.com. Orlando, FL (PRWEB) October 07, 2011 Algorithm for Estimating Mealtime Insulin Dose More Effective than Carb Counting: A team of researchers at the University of Sydney in Australia has discovered a new food insulin index (FII) algorithm for...

2011-09-01 13:00:00

INDIANAPOLIS, Sept. 1, 2011 /PRNewswire/ -- Roche Diabetes Care, makers of the ACCU-CHEK® portfolio of diabetes management products and services, is proud to host its second annual Infusion Site Awareness Week, Aug. 29-Sept. 4, a week-long effort to highlight the importance of proper infusion site management for the 400,000 people in the United States with Type 1 diabetes who use an insulin pump. "The inaugural Infusion Site Awareness Week, which was launched during the...

2011-07-25 06:30:00

BRIDGEWATER, N.J., July 25, 2011 /PRNewswire/ -- Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it received CE Mark approval for its V-Go(TM) Disposable Insulin Delivery Device as well as ISO 13485: 2003 Quality Management System Certification. The V-Go is designed to provide simple basal-bolus therapy for adults who require insulin therapy. "These are important corporate milestones for...

2011-07-21 01:00:00

HIGH WYCOMBE, England, July 21, 2011 /PRNewswire/ -- Using the waterproof* Animas(R) Vibe(TM) Insulin Pump and CGM System, People with Diabetes to Participate in Channel Swim Relay Six swimmers congregate along the Dover coastline today, to participate in a 17-hour relay swim across the English Channel to France. The relay event, sponsored by Animas(R),aims to raise money for the Juvenile Diabetes Research Foundation (JDRF) and celebrate people with diabetes performing...

2011-06-27 12:17:32

The 25.8 million Americans who have diabetes may soon be free of finger pricks and daily insulin dosing. Mayo Clinic endocrinologists Yogish Kudva, M.B.B.S., and Ananda Basu, M.B.B.S., M.D., are developing an artificial pancreas that will deliver insulin automatically and with an individualized precision never before possible. As part of this effort, Drs. Kudva and Basu will present their latest findings on how the mundane movements of everyday life affect blood sugar to the American Diabetes...